解放军药学学报2024,Vol.37Issue(2) :95-99.DOI:10.3969/j.issn.1008-9926.2024.02.001

我国静脉用药现状与监管措施系统分析

Current Management of Intravenous Medications in China

文爱东 张迪 张娟利 樊婷婷 丁莉坤 任丹君 刘美佑 王婧雯
解放军药学学报2024,Vol.37Issue(2) :95-99.DOI:10.3969/j.issn.1008-9926.2024.02.001

我国静脉用药现状与监管措施系统分析

Current Management of Intravenous Medications in China

文爱东 1张迪 1张娟利 1樊婷婷 1丁莉坤 1任丹君 1刘美佑 1王婧雯1
扫码查看

作者信息

  • 1. 710032 陕西西安,空军军医大学第一附属医院
  • 折叠

摘要

分析我国静脉用药现状和存在问题,结合国内外管理策略和应用指南,提出改善我国静脉用药现状的措施.通过建立有效的监管机制、制定统一的指导原则、落实静脉用药准则、强化人员工作职能、完善人员培训教育等方面加强静脉用药监管,限制静脉输液过度使用、降低不合理用药现象,保障全民用药健康安全.

Abstract

According to the management methods and guidelines at home and abroad,the status quo of and potential problems with intravenous medications in China were analyzed while strategies to tighten the control of intravenous infusion were recommended:such as the establishment of an effective supervision mechanism,formula-tion of uniform guidelines,implementation of norms for intravenous drugs,strengthening of personnel functions,and upgrading of personnel training in order to curb the overuse of intravenous infusion,reduce irrational drug use,and ensure the health and safety of patients in China.

关键词

静脉用药/药品不良事件/合理用药/静脉用药监管措施

Key words

intravenous infusion/adverse drug event/rational drug use/intravenous infusion management measure

引用本文复制引用

出版年

2024
解放军药学学报
中国人民解放军总后勤部卫生部 药品仪器检验所

解放军药学学报

CSTPCD
影响因子:0.529
ISSN:1008-9926
参考文献量32
段落导航相关论文